Pharma News

Gorilla Origins of Two Human Aids Virus Lineages Confirmed

  • Posted on: 19 March 2015
  • By: PharmaTutor News

Two of the four known groups of human AIDS viruses originated in western lowland gorillas in Cameroon, according to a new study. An international team of scientists from the Perelman School of Medicine at the University of Pennsylvania, the University of Montpellier, the University of Edinburgh, and colleagues conducted a comprehensive survey of simian immunodeficiency virus (SIV) infection in African gorillas.

Emergent joins with GSK & NIAID for the production of Ebola Vaccine

  • Posted on: 18 March 2015
  • By: PharmaTutor News

Emergent BioSolutions under several agreements signed with the Oxford university, GSK and the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) respectively, it has manufactured a modified vaccinia Ankara (MVA) Ebola Zaire vaccine candidate (MVA EBOZ) anticipated for use in a Phase 1 clinical study to be conducted by Professor Adrian Hill of the Jenner Institute.

India Unveils Rotavirus Vaccine, Claimed to be Cheapest

  • Posted on: 17 March 2015
  • By: PharmaTutor News

India unveiled its indigenously developed and manufactured Rotavirus vaccine, claimed to be the world's cheapest at the rate of around Rs 60 per dose and aimed at boosting efforts to deal with diarrhoea that kills upto 80,000 children under 5 every year.

Lupin fully acquires South African generic company

  • Posted on: 17 March 2015
  • By: PharmaTutor News

Pharmaceutical Major Lupin has entered into an agreement to acquire the balance 40% equity stake in South African generics major, Pharma Dynamics(PD) from its founders. As per the agreement, the founders will exercise their put option before March 31,2015, for the 40% equity stake it currently holds. On completion of this transaction, PD will become a wholly owned subsidiary of Lupin.

Indian Scientist Awarded 1.5 Million Euros Grant

  • Posted on: 16 March 2015
  • By: PharmaTutor News

A young Indian scientist based in Germany has been awarded a grant of 1.5 million euros to investigate the role of gut microbiota in autoimmune diseases of the central nervous system such as Multiple Sclerosis. The Starting Grants of the European Research Council (ERC) seek to give talented scientists at an early stage in their careers the freedom to pursue their most creative ideas.

Pages